(Q34697510)

4 August 2017

Behavioral and pharmacological validation of the gerbil forced-swim test: effects of neurokinin-1 receptor antagonists (English)

1 reference

4 August 2017

1 reference

Tanya L Wallace-Boone

1

1 reference

4 August 2017

Amy E Newton

2

1 reference

4 August 2017

Robert N Wright

3

1 reference

4 August 2017

Nicholas J Lodge

4

1 reference

4 August 2017

John F McElroy

5

1 reference

4 August 2017

language of work or name

English

0 references

publication date

3 October 2007

1 reference

4 August 2017

Neuropsychopharmacology

1 reference

4 August 2017

33

1 reference

4 August 2017

8

1 reference

4 August 2017

1919-1928

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301586

4 August 2017

0 references

cites work

Sex differences in behavioral despair: relationships between behavioral despair and open field activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Ethopharmacology of imipramine in the forced-swimming test: gender differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Is the forced swimming test a suitable model for revealing antidepressant activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Automated tests for measuring the effects of antidepressants in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Assessing antidepressant activity in rodents: recent developments and future needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Diazepam and nicotine increase social interaction in gerbils: a test for anxiolytic action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Species differences in affinities of non-peptide antagonists for substance p receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Learned helplessness: Theory and evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Preclinical models: status of basic research in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Behavioural despair in rats: A new model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Depression: a new animal model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

From monoamines to genomic targets: a paradigm shift for drug discovery in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Pharmacokinetics and effects of haloperidol in the isolated mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

7 January 2021

Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

7 January 2021

Group housing of mice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

7 January 2021

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

7 January 2021

“Behavioural despair” in rats and mice: Strain differences and the effects of imipramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

7 January 2021

The tail suspension test: a new method for screening antidepressants in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

7 January 2021

Effect of changes in swimming area on results of "behavioral despair test"

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

7 January 2021

Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301586

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301586

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference